首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1897349

营养保健品和疫苗市场规模、份额和成长分析（按产品类型、应用、剂型、分销管道和地区划分）－2026-2033年产业预测

Nutraceutical & Vaccine Market Size, Share, and Growth Analysis, By Product Type, By Application, By Formulation Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 202 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球营养保健品和疫苗市场规模将达到 613.8 亿美元，到 2025 年将增长至 660.4 亿美元，到 2033 年将增长至 1186.7 亿美元，在预测期（2026-2033 年）内复合增长率为 7.6%。

全球营养保健品和疫苗市场正经历强劲成长，这主要得益于消费者健康意识的不断提高。营养保健品，包括机能性食品和膳食补充剂，因其潜在的健康益处和疾病预防作用而日益受到欢迎，从而带动了需求的增长。同样，由于对疾病预防的重视、技术的进步以及全球免疫接种工作的扩展，疫苗产业也蓬勃发展。各国政府和组织为确保疫苗的普及所做的努力进一步推动了市场成长。此外，联合国儿童基金会和世界卫生组织等机构的策略正在为改善疫苗可及性铺平道路。消费者越来越认识到营养在降低医疗保健成本方面的重要性，这推动了营养保健品市场的发展，使其成为健康管理和预防保健的重要组成部分。

全球营养保健品和疫苗市场成长要素

推动全球膳食补充剂和疫苗市场成长的关键因素是人们对预防性医疗保健日益增长的关注。随着人们越来越意识到整体健康和疾病预防的重要性，对具有健康益处和增强免疫系统的产品需求激增。消费者正积极主动地关注自身健康，并且越来越多地寻求营养保健品和疫苗。这一趋势受多种因素驱动，包括生活方式的改变、人口老化以及人们越来越希望透过优先考虑疾病预防而非仅依赖治疗来降低医疗保健成本。

限制全球营养保健品和疫苗市场的因素

全球营养保健品和疫苗市场面临的主要挑战之一在于其复杂的法规结构和核准流程。营养保健品和疫苗的研发和上市需要进行广泛的测试、临床试验，并遵守严格的监管标准，以确保其安全性、有效性和品质。这些繁琐的程序耗时且耗力，对市场参与企业构成了障碍，尤其是资源有限的中小型企业。此外，严格的监管还会延缓产品上市，增加合规成本，阻碍营养保健品和疫苗产业的成长，并抑制创新。

全球营养保健品与疫苗市场趋势

全球营养补充品和疫苗市场正呈现出向个人化医疗解决方案显着发展的趋势。这项转变源自于消费者日益青睐根据自身健康状况和遗传倾向量身订製的产品。基因组学、个人化医疗和先进数据分析领域的创新对于实现个人化营养和疫苗接种策略至关重要。为此，各公司正加速研发针对特定健康问题并提高疗效的个人化营养保健品和疫苗。这一趋势预示着精准医疗正在蓬勃发展，它强调识别和应对个别健康差异的重要性，以实现最佳治疗效果。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

GlaxoSmithKline plc（GSK）（United Kingdom）
Pfizer Inc.（United States）
Sanofi Pasteur（France）
Merck & Co., Inc.（United States）
Moderna, Inc.（United States）
Novavax, Inc.（United States）
CSL Limited（Australia）
AstraZeneca plc（United Kingdom）
Johnson & Johnson（United States）
Bavarian Nordic A/S（Denmark）

结论与建议

简介目录

Product Code: SQMIG35I2337

Global Nutraceutical &Vaccine Market size was valued at USD 61.38 Billion in 2024 and is poised to grow from USD 66.04 Billion in 2025 to USD 118.67 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global nutraceutical and vaccine market is experiencing robust growth, fueled by heightened consumer awareness of health and wellness. Nutraceuticals, including functional foods and dietary supplements, are increasingly favored for their health benefits and disease prevention potential, leading to rising demand. Similarly, the vaccine sector is thriving, driven by a focus on disease control, advancements in technology, and expanded immunization initiatives globally. Commitment from governments and organizations to ensure universal access to vaccines has further enhanced growth. Additionally, strategies from entities like UNICEF and WHO are paving the way for improved vaccine accessibility. Consumers are recognizing the importance of nutrition in reducing healthcare costs, thus propelling the nutraceutical market as a vital component of health management and preventive care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutraceutical &Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical &Vaccine Market Segments Analysis

Global Nutraceutical & Vaccine Market is segmented by Product Type, Application, Formulation Type, Distribution Channel and region. Based on Product Type, the market is segmented into Vaccines and Dietary Supplements. Based on Application, the market is segmented into Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Disease Prevention and Weight loss. Based on Formulation Type, the market is segmented into Tablets, Capsules, Powders and Liquids. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Sales and Super Markets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nutraceutical &Vaccine Market

A key catalyst for growth in the global nutraceutical and vaccine market is the heightened focus on preventive healthcare. As individuals become more aware of the significance of promoting overall wellness and mitigating diseases, there is an escalating demand for products that provide health benefits and strengthen the immune system. Consumers increasingly pursue nutraceuticals and vaccines, reflecting a proactive approach toward their health. This trend is driven by various elements, including evolving lifestyles, an aging demographic, and a growing desire to lower healthcare expenses by prioritizing the prevention of illnesses instead of relying solely on treatments.

Restraints in the Global Nutraceutical &Vaccine Market

A significant challenge faced by the global nutraceutical and vaccine market lies in the complex regulatory frameworks and approval processes. The pathway for developing and bringing nutraceuticals and vaccines to market necessitates thorough testing, clinical trials, and compliance with rigorous regulatory standards to guarantee safety, efficacy, and quality. These demanding procedures can be both lengthy and expensive, creating obstacles for market participants, particularly for smaller firms with constrained resources. Additionally, stringent regulations may lead to delays in product introduction and escalate compliance costs, which can stifle growth and hinder innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical &Vaccine Market

The global nutraceutical and vaccine market is witnessing a notable trend towards personalization and customization in healthcare solutions. This shift is driven by an increasing consumer preference for products that align with their unique health profiles and genetic predispositions. Innovations in genomics, personalized medicine, and advanced data analytics are pivotal in enabling tailored nutrition and vaccination strategies. As a response, companies are increasingly formulating personalized nutraceuticals and vaccines that address specific health issues and enhance efficacy. This trend signifies a broader movement towards precision healthcare, emphasizing the importance of recognizing and catering to individual health variations for optimal therapeutic results.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Nutraceutical & Vaccine Market Size by Product Type & CAGR (2026-2033)

Market Overview
Vaccines
Dietary Supplements

Global Nutraceutical & Vaccine Market Size by Application & CAGR (2026-2033)

Market Overview
Sports Nutrition
General Well-Being
Immune & Digestive Health
Bone & Joint Health
Heart Health
Disease Prevention
Weight loss

Global Nutraceutical & Vaccine Market Size by Formulation Type & CAGR (2026-2033)

Market Overview
Tablets
Capsules
Powders
Liquids

Global Nutraceutical & Vaccine Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Sales
Super Markets

Global Nutraceutical & Vaccine Market Size & CAGR (2026-2033)

North America (Product Type, Application, Formulation Type, Distribution Channel)
- US
- Canada
Europe (Product Type, Application, Formulation Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Formulation Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Formulation Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Formulation Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GlaxoSmithKline plc (GSK) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments